Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing Surgery

NCT00157105 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

59

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia A

Interventions

DRUG: Antihemophilic factor, recombinant, manufactured protein-free

Sponsor

Baxalta now part of Shire